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 Helicobacter felis (H. felis) infection has been used for numerous years as a 
standard model of gastric carcinogenesis and recapitulates the pathogenesis seen with 
human Helicobacter pylori infection. H. felis induces a a wide array of chronic low grade 
inflammatory responses, some of which directly contribute to carcinogenesis and some 
of which do not. To tease out the role of various processes, we have compared and 
contrasted models that recapitulate H. felis infection or synergize with it, namely, the 
K19kras transgenic mouse, and diet-induced obesity, respectively. While much attention 
has been rightly paid to the behavior of transformed cells, some focus has recently 
shifted to the components of the soil in which tumors develop and grow, commonly 
referred to as the microenvironment. Here, we investigate the gastric tumor 
microenvironment and shed light on the role of myofibroblasts, T lymphocytes and 
myeloid cells.
 K19kras mice express a mutant K-ras transgene in K19+ cells of the stomach; 
while K19 (and therefore the transgene) is not expressed in candidate stem/progenitor 
cells of the gastric corpus (marked by Dcamkl1 expression), a severe expansion and 
repositioning of Dcamkl1+ cells is observed in this model, and correlates with the 
accumulation of αSMA+ myofibroblasts and recruitment of bone marrow-derived 
inflammatory cells surrounding glands. These transgenic mice also progress to high 
grade dysplasia at a similar rate as H. felis-infected mice, and this correlates with 
expression of select cytokines and chemokines expressed in both models, namely IL-6, 
IL-1β, and CXCL1.
 While H. felis infection had no effect on the phenotype of K19kras mice, 
epidemiological studies have shown that in humans, obesity increases one’s risk of a 
wide variety of cancers, including gastric cancer, and indeed, we noted a synergy when 
recapitulating this in the mouse model. Acceleration in dysplasia progression was 
correlated with elevated levels of serum IL-6 and Leptin, which translated to excessive 
Stat3 activation in both epithelial and stromal compartments of the gastric epithelium, 
and excessive production of IL-17A in obese, H. felis-infected mice. As some reports 
indicate the TH17 response (characterized by IL-17A production) can, in certain contexts, 
promote tumorigenesis, it may be fundamental to H. felis-induced gastric 
carcinogenesis, and be a mechanism by which obesity accelerates cancer development.
 Another important component of the tumor microenvironment, as described 
previously in the H. felis and other cancer models are myeloid cells. Namely, a group of 
phenotypically immature myeloid cells have been termed IMCs (immature myeloid cells), 
and can both suppress anti-tumor immunity and express mediators that directly promote 
carcinogenesis. IMCs were recruited from the bone marrow in H. felis-infected mice, 
although unexpectedly, these cells were intercepted by expanded adipose tissue (in 
obese mice), where they differentiated into mature macrophages.  This led to an overall 
increase in the number of myeloid cells in the adipose tissue of obese H. felis-infected 
mice when compared to uninfected obese mice, and most importantly, an increase in 
adipose CD11b+F4/80+CD11c+ myeloid cells, which are known to be a primary source of 
insulin resistance-inducing adipokines. Fittingly, obese H. felis-infected mice had 
significantly higher levels of IL-6, resistin, and PAI-1, and were more glucose intolerant 
than uninfected obese mice.  Myeloid proliferation was similar between the two groups 
(as measured by KI67 and BrdU), as well as myeloid chemotaxis from the blood into 
adipose tissue (as determined by CCL chemokine production). Therefore, excessive 
myeloid recruitment to the adipose tissue could be due to elevated myeloid cells in the 
blood, which in turn is due to mobilization from the bone marrow. Indeed, we noted 
slightly elevated levels of blood IMCs in uninfected obese mice and H. felis-infected lean 
mice; in an additive fashion, this led to significantly elevated levels in obese H. felis-
infected mice. Blood myeloid concentration was correlated with serum levels of the 
recently identified IMC mobilizer CXCL1, which was produced by H. felis-infected gastric 
tissue, and obese adipose tissue.
 Collectively, these results further stress the role of desmoplasia in gastric 
carcinogenesis. The recruitment of bone marrow derived cells may lead to the 
engraftment of myofibroblasts in the stem cell niche and permanently alter signals 
regulating stem cell homeostasis. This, in turn, may increase the number of long-lived 
undifferentiated progenitors which can accumulate multiple mutations and initiate 
tumors. Furthermore, interaction and cytokine production by components of the 
inflammatory microenvironment, namely IL-6, IL-1β, and IL-17 (Stat3 and NFκB 
activators) initiate and maintain cell transformation and promote their progression. 
Finally, the recruitment of cells that participate in the tumor microenvironment may have 
unintended side effects if they are intercepted by other tissues, as exemplified here in 
the exacerbation of insulin resistance.
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Chapter 1: Introduction
I. Gastric stem cells and their niches 
 The human and murine stomach is divided into at least three regions based on 
histological and physiological differences. Both mice and humans have a corpus (closest 
to the esophagus) and antrum (closest to the small intestine). Humans have a glandular 
fundus while mice have a keratin-rich forestomach (Figure 1). As the phenotypes in both 
mouse models discussed in this thesis occur in the gastric corpus, any references to the 
gastric epithelium will be that of the corpus unless otherwise noted. The gastric 
epithelium encounters a barrage of  environmental factors and is constantly in a state of 
regeneration to replace cells before they are damaged beyond repair. Estimates suggest 
that some differentiated cell types in the gastric epithelium last as little as 3 days, while 
others live as long as 190 days1. It is generally believed that a “tissue stem cell” resides 
in the gastric epithelium which ultimately can give rise to the at least 7 different cell types 
in the corpus2. Here, the tissue stem cell will be defined as it has in other tissues, in that 
it lives indefinitely, can divide asymmetrically (give rise to itself and a daughter cell), and 
gives rise to all cell types of the (regional) tissue. 
 Tissue stem cells are thought to be quiescent, so initial experiments utilized 
BrdU (a thymidine analog) retention to localize candidate cells to the isthmus of the 
gastric corpus (Figure 1). Fittingly, this region also retains proliferating (KI67+) cells, 
which are thought to be one or more type(s) of transit amplifying/progenitor cells, whose 
job is to reconstitute the epithelium in the short term; however, it is able to produce a 
more limited number of differentiated cell types. The gastric epithelium is organized into 
glands, around 20-30 cells high and 6 cells around. Current theory places one stem cell 
and 10 progenitor cells per gland; with histological slices spanning 5 micrometers (µm), 
or about 1/6th of a gland, a cell type with the frequency of roughly 1 every 6 glands has 
been sought after in histological sections3. To date, the closest candidate have been 
cells expressing Doublecortin and CaM Kinase-Like 1 (Dcamkl1). Dcamkl1+ cells reside 
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in the neck/isthmus region of stomach glands, do not express biomarkers associated 
with differentiated lineages, and are generally found once every 6-8 glands3,4. However, 
definitive data (and indeed the gold standard of tissue stem cell research) is lineage 
tracing using the cre/lox system.  To date, our lab has created a Dcamkl1-cre mouse, 
although we are currently collecting and interpreting data in what seems to be a complex 
situation. To our knowledge, no one else reported the generation of  a Dcamkl1-cre 
mouse, or used any other marker that has successfully lineage traced an entire gland in 
the adult gastric corpus. Nonetheless, it is important to characterize the behavior of  all 
the cell types of the gastric epithelium, especially putative stem cell markers, during 
homeostasis as well as pathology.
 Stem cells do not live alone, and they must take in and interpret information 
from their surroundings to meet the demands of  the tissue. While the stem cell may 
respond to distant signals, it is thought that regulatory elements come from a more 
proximal “niche.” Again, as the gastric tissue stem cell has not been identified, neither 
have the niche cells, or the factors coming from them. However, stromal cells, primarily 
consisting of fibroblast-like cells are likely involved, and relay information to the tissue 
stem cells via morphogens and cytokines. 
II. The cancer stem cell hypothesis
 Cancer is a very complex system, typically taking many years to develop, and 
must bypass a large number of regulatory mechanisms to survive and grow. Therefore, 
as many differentiated cell types in the gastric epithelium live only 14-21 days, it is likely 
that other, longer-lived cells types develop the multiple mutations to generate cancer. 
This is the basis of  the “cancer stem cell” hypothesis and points to tissue stem and/or 
progenitor cells.
 Classically, the search for cancer stem cells/cells-of-origin of  cancers have 
employed in vivo and ex vivo approaches. The primary ex vivo approach involves 
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digesting whole tumors and using cell surface markers to isolate populations that, when 
injected into immunocompromised hosts, generate tumors that are phenotypically 
identical to the original. Frequently, multiple markers are needed to find highly purified 
populations that generate tumors with the greatest efficiency. While this approach has 
been successfully used to identify cells from prostate5, colon6,7, pancreatic8,9, and other 
cancers, only CD44 has been reported to enrich a cancer stem cell population from 
gastric cancer cell lines10. However, CD44 is not expressed in the corpus stem cell zone, 
and its function in both normal and transformed gastric tissue remains ill-defined.
  The primary in vivo approach involves expressing mutant oncogenes and/or 
knocking out tumor suppressors under the control of candidate cancer stem cell 
markers. Some examples include RIP-mediated Kras activation for pancreatic tumors11; 
Nkx3.1-mediated12, Probasin-mediated13, and Prostate Specific Antigen-mediated14,15 
PTEN inactivation for prostate tumors; K14-mediated Smoothened activation for basal 
cell carcinoma tumors16; and Lgr5-mediated APC inactivation17, and CD133-mediated18, 
and BMI1-mediated19 mutant β-catenin expression for intestinal tumors. Again, markers 
in the gastric corpus are currently lacking but will be pivotal to our understanding of the 
genesis of gastric tumors.
 Finally, candidate markers can be supported by additional lineage tracing during 
standard tumor-inducing condition. Our lab is actively pursuing the above approaches 
(primarily utilizing the markers Dcamkl1 and K19) to help understand normal stem cell 
and cancer stem cell behavior in the gastric epithelium.
III. The seed and soil hypothesis
 As noted above, stem cells do not live isolated, and this is the same case for 
cancer cells/cancer stem cells. Many have likened the cancer stem cell to a seed, it 
contains all of  the instructions and potential to grow  into a massive entity.  Although, just 
as a seed cannot spontaneously grow  into a plant without proper and nutritional soil, a 
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cancer stem cell cannot expand and metastasize without the proper microenvironment. 
Therefore, in recent years, some focus has shifted from studying the cancer cell itself to 
studying the components of the tumor microenvironment. This not only includes 
endogenous members of the normal stem cell niche that have gone awry, but additional, 
ectopic cell types that can either signal to the cancer (stem) cell, the niche cells, or both. 
In many tissues, there are a variety of  fibroblastic-shaped cells that express different 
antigens; they constitute a significant proportion of the stroma and are thought to provide 
a multitude of signals that maintain homeostasis. Generally, a majority of  fibroblasts are 
desmin+ and/or vimentin+ and a small number are α-smooth muscle actin (αSMA)+ 
fibroblasts (also known as myofibroblasts). However, tumorigenesis leads to 
development of  abnormal stroma, typically referred to as desmoplasia, that favors tumor 
growth over tissue homeostasis. In gastric tissue, this is generally characterized by a 
relative decrease of desmin/vimentin+ fibroblasts and an increase in αSMA+ 
myofibroblasts, and approximately 15-25% of myofibroblasts are reported to be bone 
marrow-derived cells (BMDCs)20-22. While BMDCs have the ability to differentiate into 
cell types that support normal homeostasis, recent evidence suggests that tumors may 
exploit their plasticity by secreting factors which instead causes them to differentiate into 
myofibroblasts, and in turn support the growth of the developing tumors22-25.
 A wide variety of hematopoietic cells are also an integral part of the tumor 
microenvironment, and indeed, many cancers arise in the setting of  chronic 
inflammation26. It is clear that the immune system orchestrates different types of 
responses for different pathogens; although, which type of  response and what 
components of  these responses mediate the development of tumors is incompletely 
defined. Pro-inflammatory responses likely play a role in both the initiation and 
promotion of tumors27 and can lead to oncogenic mutations, in part, by inducing 
proliferation and increasing the mutation rate28. Furthermore, inflammatory cells are an 
important source of  anti-apoptotic signals, pro-angiogenic factors, and extracellular 
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matrix remodeling enzymes, all of which support tumor growth26. However, anti-
inflammatory responses also appear to be critical in tumor development. Transformed 
cells can be recognized as abnormal/foreign and destroyed by members of  the innate 
immune response, such as macrophages, natural killer cells, and dendritic cells, and by 
adaptive immune cells, such as CD8+ T cells, when appropriately activated29. Although, 
tumors exploit immunosuppressive mechanisms to subvert this cell-mediated immunity, 
and these topics are discussed below.
 The immune responses in which tumors arise (frequently induced by unresolved 
viral or bacterial infections) are complex, although utilization of a wide variety of  models 
has brought two transcription factors into the spotlight: Stat3 (Signal Transducers and 
Activators of  Transcription 3) and NFκB (Nuclear Factor Kappa B). With respect to tumor 
cells, a potentially imperative feed-forward loop was recently identified, whereby NFκB 
activates Lin28B (an RNA editing enzyme) which rapidly reduces Let7 levels (a 
microRNA), thereby lifting Let7’s inhibition of  IL-6 expression30. As IL-6 leads to 
activation of  NFκB, this creates a feed forward loop, whose activation is required for both 
initial transformation and maintenance of transformed cells30. While the members of this 
loop are critical, the actual transformation is primarily mediated by Stat3 (with an 
overlapping and supportive role of NFκB), through activation of a wide variety of  pro-
survival and anti-apoptotic pathways, such as BCL-XL, BCL-2, MCL1, survivin, cyclin D1 
and MYC29,31-33. Furthermore, Stat3 has been shown to induce the expression of a wide 
variety of  pro-angiogenic factors, such as HIF1α (hypoxia-inducible factor 1α), bFGF 
(basic fibroblast growth factor), HGF (hepatocyte growth factor), MMP2 (matrix 
metalloproteinase 2), and MMP931. 
 While the above mechanism most directly relates to developing transformed 
cells, both NFκB and Stat3 activation are also imperative in stromal cells, and indeed, 
are frequently concomitantly and constitutively activated in both epithelial and stromal 
components of  tumors29,34. NFκB is a multi-component transcription factor, of which one 
6
subunit position is held by either REL (also known as c-Rel), RELA or RELB and the 
other by p50 or p52. The RELA-p50 heterodimer is the prototypical NFκB transcription 
factor, and it is crucial for the expression of  genes encoding the cancer-promoting, pro-
inflammatory mediators such as IL-6, IL-1β, Cox2, and IL-2335. Although tumor cells are 
known to produce some of these mediators for autocrine stimulation, they are mainly 
produced by the stromal inflammatory cells29,31. In contrast, the REL-p50 heterodimer 
mainly activates expression of T helper type 1 (TH1) immunostimulatory genes involved 
in anti-tumor immunity, including IL-12, CD40 and CD8035. However, Stat3 inhibits the 
expression of  NFκB target genes involved in innate and adaptive responses important 
for controlling tumor growth29, as discussed below. With respect to constitutive 
activation, Stat3 induces p300-mediated acetylation of  RELA, trapping it in the nucleus 
and thereby contributing to constitutive NFκB activation in cancer36,37. Furthermore, 
Stat3 can also act as a co-transcription factor with RELA for the expression of many 
inflammatory mediators, including IL-6, Cox2, IL-17, and IL-23, all of which, in turn, can 
activate Stat331. 
 While Stat3 has an obvious and important role in epithelial cell transformation, its 
activation in stromal cells is involved in the inhibition of  anti-tumor immunity. TH1-type 
responses are generally used by the immune system to control the expansion of 
intracellular pathogens such as viruses and certain bacteria, by targeting and destroying 
infected cells. Heavily involved in this process is the activation of Stat1 in which leads to 
IL-12 production; binding to the IL-12 receptor leads to Stat4 activation, which, in turn 
promotes the production of  IFNγ in CD4+ TH1 cells. IFNγ itself signals through Stat1 to 
increase anti-tumor responses in CD8+ T cells, natural killer cells, and macrophages 
through their cytolytic activity38,39. Although distinct subgroupings of  NFκB can induce 
Stat1-mediated expression of anti-tumor TH1 cytokines such as IL-12 and IFNγ, Stat3 is 
able to antagonize Stat1, and restrain these processes40-42. Consistent with this, ablating 
Stat3 in natural killer cells and macrophages can boost expression of  TH1 mediators43,44, 
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leading to Stat1 upregulation and increased anti-tumor immune responses45. The 
immune system also has mechanisms in place that are normally used during microbial 
infection to restrict over-active responses. These include T regulatory cells (Treg) and 
myeloid derived suppressor cells (MDSCs), and are exploited by tumors to avoid TH1-
associated immunity against transformed cells46. Again, Stat3 plays a leading role in this 
exploitation, cooperating with Stat6 to promote the immunosuppressive effects of 
MDSCs and other myeloid cells47-49, and cooperating with Stat5 to expand the pool of 
Tregs40. Collectively, while Stat3 and NFκB have their independent roles in the 
inflammation frequently seen in carcinogenesis, co-activation of these transcription 
factors in the same cell (and/or group of cells) may result in a co-dependent, persistent 
activation that ensures continued expression of their cancer-inducing mediators. 
Furthermore, these studies suggest that Stat3 is an attractive target for cancer therapies, 
and indeed, antagonists are actively being developed. Although limited studies have 
suggested that broad Stat3 inactivation can lead to autoimmune disorders and other 
comorbidities, its restricted use, in combination with other therapies, may very well 
become standard in future years31.
IV. Helicobacter infection and gastric cancer
 Although there has been an overall decline in incidence and death, as of  2010, 
gastric cancer remains the fourth most common cancer and the second leading cause of 
cancer related death50. A near prerequisite for gastric cancer is infection with 
Helicobacter pylori (H. pylori), which is considered a Class 1 carcinogen by the World 
Health Organization. H. pylori is a bacteria that chronically infects the stomachs of  nearly 
half  the world, and causes a low-grade inflammation that can lead to gastric 
inflammation (gastritis), and eventually peptic ulcers or gastric cancer in approximately 
10-15% or 1-3% of  those infected, respectively28. H. pylori infection is typically acquired 
early in life and is followed by a long quiescent phase where chronic gastritis of variable 
8
intensity lingers with minimal symptoms. Peptic ulcers tends to develop in patients in 
their 20s and 30s, whereas gastric cancer arises several decades later. Interestingly, 
patients who develop H. pylori-associated duodenal ulcers seem to be somewhat 
protected from developing gastric cancer51. The distinct pathways that result in 
differential clinical and pathological outcomes appear to be regulated by the location and 
intensity of the host’s immune response, which, in turn, is likely due to both host and 
bacterial genetics, and possibly other environmental factors. Indeed, early 
histopathological characterization of  H. pylori infected stomachs by Dr. Correa clearly 
conveyed that multifocal atrophic gastritis was most prevalent in the same population 
that had an increased risk of gastric cancer, whereas those with gastritis restricted to the 
antrum were at lower risk52,53. Long-term investigative studies noted that this multifocal 
gastritis was associated with the development of precursor lesions including intestinal 
metaplasia and atrophic gastritis. Intestinal metaplasia is defined by pathologists as the 
replacement of original gastric glands with cell types typically found in the more distal 
gut, such as absorptive and goblet cells54. Conversely, atrophic gastritis is defined as the 
presence of  inflammatory infiltrates with the loss of  specialized glandular tissue, such as 
parietal cells in oxyntic glands of the gastric corpus54. These two phenomena can, but do 
not always, happen concomitantly, and it is thought that atrophic gastritis is a better 
indicator of  gastric cancer risk. Interestingly, atrophic gastritis is always associated with 
two additional, more recently described types of  metaplasia, including pseudopyloric 
metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM)28. It should be 
noted that cancer formation is correlated with, but not directly dependent upon, 
inflammation. Increasing the severity of  gastritis does not always lead to accelerated 
gastric carcinogenesis, and this should be kept in mind when analyzing immune 
responses, particularly TH1 and TH17 (discussed in the following section).
 While standard H. pylori strains do not readily infect the murine stomach, 
Helicobacter felis (H. felis) does, and has been used as an analogous mouse model of 
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the human infection55. H. pylori and H. felis are very unique in that they are able to thrive 
in the acidic environment of the stomach. Critical factors allowing their colonization and 
survival include the ability to produce large amounts of the enzyme urease, which 
hydrolyzes urea to ammonia and carbon dioxide, thereby neutralizing gastric acid. In 
addition, their powerful flagella allow  them to be motile in the mucus layer overlying the 
gastric epithelium. They also produce enzymes that break down the surfactant layer over 
the gastric epithelium, allowing them to access to nutritional components of the host28. 
Although about 10% of H. pylori and felis can adhere to gastric epithelial cells and are 
found intracellularly on rare occasions, a majority of the bacteria live extracellularly and 
nonadherant in the mucus environment56-58. This could account for the lack of efficacy of 
immune-mediated clearance and difficulty in achieving antibiotic mediated eradication. 
 Early immune population depletion studies with H. felis-infected mice found that 
host T cells were essential for the development of severe atrophy and metaplasia, 
whereas depletion of B cells had little effect59,60. Subsequent studies have shown that 
gastritis is enhanced in H. felis-infected immunodeficient mice after transplantation with 
splenocytes, total CD4+ T cells, or TH1 cells from wild type mice60,61. Additional evidence 
supporting a role for T cell responses, namely TH1 responses, has been noted in mouse 
strains susceptible to gastric atrophy after H. felis infection, such as C57BL/6 mice; 
conversely, strains such as BALB/c mount TH2 responses and are relatively resistant to 
atrophy and dysplasia28. 
 In addition to the cytokine environment provided by T cells, which are important 
for the initiation and progression of tumors (detailed in the next section), H. pylori and 
felis can induce changes in the glandular composition. As noted, atrophic gastritis is the 
loss of specialized cell types in corpus glands, of which the best studied include parietal 
cells. Using a transgenic approach to ablate parietal cells via expression of the 
diphtheria toxin receptor, an increase in proliferation and accumulation of 
undifferentiated candidate progenitors is observed1. The core of any tissue homeostasis 
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are the signals transmitted between the various cell types, and in this case, differentiated 
cells signal to the stem cells and/or its niche to control proliferation and output. One 
promising morphogen that is detected by immunohistochemistry in normal parietal 
cells62, yet is lost in patients with atrophic gastritis63 is Sonic Hedgehog (SHH). 
Extending these data, it has been shown that SHH-deficient mice develop a metaplasia 
of the stomach64. 
  The loss of parietal cells not only leads to a reduction in important differentiation 
signals, but also leads to the loss of gastric acid secretion (achlorhydria), and 
consequently, a rise in pH. This allows the growth of  non-Helicobacter bacterial species 
that normally could not survive in the acidic environment, and affect pathological 
outcomes. Indeed, it has become clear from studies in achlorhydric mice that bacteria 
other than Helicobacter can induce atrophic gastritis65. It is known that colonization of  H. 
pylori declines over time in patients with severe achlorhydria, and it is often difficult to 
detect in patients with gastric cancer66. This has lead to an evolution in the view  of  H. 
pylori’s role in carcinogenesis; whereby it may primarily act as a trigger for the 
development of gastric atrophy and achlorhydria rather than as a direct promoter of 
advanced gastric cancer. Evolution in technology has allowed the characterization of  a 
number of non-Helicobacter species in the mouse and human gut, primarily in the distal 
regions of the cecum and colon67-69. There is little to no correlative or mechanistic data 
on the role of  non-Helicobacter species in gastric cancer, although this is an area of 
active research70,71. Nonetheless, it is known that H. pylori and other bacteria can 
activate Stat3 (discussed in detail above) involving mechanisms including, but not limited 
to, engagement of TLR4 (Toll-Like Receptor 4; via lipopolysaccharide) or TLR972,73. 
Collectively, studies have uncovered a number of  mechanisms by which H. pylori and 
felis can directly or indirectly contribute to carcinogenesis, frequently involving 
components of the gastric microenvironment, and it is likely that a combination of 
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mechanistic effects or actions are required for efficient progression along the metaplasia-
dysplasia-cancer pathway. 
V. Obesity and cancer
 Obesity is defined as a body mass index (BMI, defined as weight (kilograms) / 
height(2) (meters)) greater than 30, and rates have been increasing dramatically over the 
past few  decades, not only around the United States, but around the world.  While there 
has been a long-standing link between obesity and diseases such as diabetes and 
atherosclerosis, epidemiologist have noted a connection to a wide variety of cancers as 
well, with both higher rates of  incidence and faster progression to death74,75. Because 
cancers generally develop over the course of decades and obesity is a relatively recent 
phenomenon that is typically restricted to western industrialized countries, data 
correlating the two remains somewhat limited. Nonetheless, earlier publications 
estimated that rates of overweight and obesity could account for 14 percent of all deaths 
from cancer in men, and 20 percent of those in women; when compared to normal 
weight controls, the heaviest group (BMI>40) had an overall relative cancer risk of  1.52 
and 1.62 in men and women, respectively76. More recently, in a large meta-analysis 
published jointly by the World Cancer Research Fund and American Institute for Cancer 
Research, it was deemed that body fatness “convincingly” increased risk for esophageal, 
pancreatic, colorectal, kidney, endrometrial, and postmenopausal breast cancers, which 
is the strongest classification due to broadly robust data74. 
 Specifically for gastric cancer, a handful of  studies have noted an increased risk 
in the obese population. Human gastric cancers are typically divided into two major 
subtypes, cardia and non-cardia. While not perfectly translating to murine tissues, 
human non-cardia cancers are more reminiscent of antral tumors in mice, and cardia 
tumors relate to far proximal regions of the murine corpus. Meta-analysis of ten studies 
in humans found that when compared to normal weight controls (20>BMI<25) the overall 
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odds ratio for gastric cardia cancer in overweight or obese subjects (BMI>25) was 1.22 
(confidence interval 1.06-1.41) and while gastric non-cardia cancer was not statistically 
significant, there was a trend towards increased risk (odds ratio 1.13, confidence interval 
0.96-1.45)77. This risk appears to increase with increasing BMI78, and is also positively 
correlated with increasing waist circumference, an indicator of visceral adiposity79.
 Limited publications have probed into the mechanism of this increased risk at 
various sites and have relied on the use of mouse models80. In a model of hepatocellular 
carcinoma, Michael Karin’s group found an association between increased tumor growth 
in obese mice with increased levels of  circulating IL-6 and TNF-α, seemingly adipose-
derived, and activation of their respective pathways in tumors81. Knockout of  IL-6 or the 
TNF receptor returned tumor incidence and growth back to levels seen in normal weight 
mice. Additional data has suggested that other adipose-derived factors may directly 
regular tumor growth and remission, including enhancing effects of leptin80,82,83, and 
potential inhibitory effects of adiponectin84,85. Although, to date, no animal models have 
been reported that investigate the potential promotion of  gastric cancer by obesity, or the 
behavior of the tumor microenvironment in these models. 
VI. The TH17 lineage
 Initial characterization of T cell responses noted a dichotomous split, and the 
term TH (T cell: helper) was coined to categorize them into TH1 and TH2 types86. 
Cytokine profiles have been modified only slightly since, and those responses heavily 
including the cytokines IFNγ, TNFα are associated with TH1 and IL-4, IL-5 are associated 
with TH2 (Figure  2). In general, TH1 responses are induced by intracellular pathogens 
such as viruses and intracellular bacteria, while TH2 responses are induced by larger 
helminths87. Since this initial classification, numerous additional types of T cell 
responses have been noted, including Treg (primarily producing anti-inflammatory IL-10), 















Figure 2: T-cell Differentiation
been taken to the TH17 response, characterized by production of  IL-17A, and to a lesser 
extent, IL-17F, IL-21, and IL-2289,90. TH17 responses are thought to be induced by 
extracellular bacteria, although have been implicated in a wide variety of  diseases such 
as EAE (experimental autoimmune encephalomyelitis), rheumatoid arthritis, 
inflammatory bowel disease, and others87.
 The signaling pathways and master regulatory transcription factors involved in 
the differentiation of  all the aforementioned T helper subtypes have been well 
characterized88. For TH1, a pathway involving Stat1 and Stat4 upregulates Tbet; TH2 
depends on Stat6 activation and GATA3. Smads are involved in upregulation of Foxp3 in 
Tregs, and Stat3 drives RORγt in TH17 cells91. In the mouse, while TGFβ has been 
associated with the development of Tregs, it appears critical in the early stages of  TH17 
cell development as well, and initiates RORγt expression92,93. After this priming, a Stat3 
activator, such as IL-6 and/or IL-21, reinforce RORγt expression and suppress Foxp3 
expression, supporting full-fledged TH17 differentiation89,94. Finally, while IL-23 does not 
seem to play a major role in TH17 development, it can support TH17 expansion and 
survival92. Dependence on these defined factors is not necessarily the case with human 
TH17 development, where IL-1β appears to induce TH17 development to a greater 
degree than TGFβ95. Recent reports have brought these human observations back to 
the mouse and noted the generation of murine TH17 cells with IL-1β and other factors in 
the absence of TGFβ96.
 IL-17A is one cytokine among a family with 5 other members, IL-17B-F97. The 
functions of  IL-17B, C, and D remain poorly defined, and IL-17E actually induces TH2 
responses.  IL-17F is more similar to IL-17A but appears to have different receptor 
affinities98. Every member of the IL-17 family is primarily found as a homodimer; 
however, IL-17A and IL-17F can additionally be found as a heterodimer97. The receptors 
for this family are similarly complex, with at least 5 members, IL-17RA-RE.  Again, they 
are generally found as homocomplexes, although IL17RA can be found in multiple 
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heterocomplexes99. To date, none have been crystalized, but it is thought that two to 
three of the single transmembrane proteins converge to form the receptor complex. For 
IL-17A and IL-17F signaling, IL-17RA and IL-17RC are required, although as mentioned, 
the three ligands (A/A, A/F, and F/F) have different affinities to different receptor 
complexes98. Receptor expression is variable between different tissues, generating an 
additional level of  IL-17 signaling regulation97. However, this overlap also means that 
extreme overexpression of  one ligand may overcome low  affinity mechanisms to induce 
signaling in unintended targets. 
 Although the complete IL-17 signaling cascade is not fully enumerated, receptor 
motifs on IL-17RA resemble those found on Toll Like Receptors (TLRs), and indeed, at 
minimum, activate similar pathways such as the canonical NFκB pathway, as well as C/
EBPβ, CEBPδ, and MAPKs97. It is not yet clear if  there are any differences downstream 
of A/A, A/F, and F/F signaling. Although, in a cell- and context-dependent manner, IL-17 
is capable of inducing the production of IL-6, IL-8, TNFα, IL-1β, PGE2 and to a lesser 
extent, other chemokines, MMPs, and growth factors99-101. To date, characterization of 
IL-17 signaling is primarily restricted to immune cells and other stromal cell types; its 
effect on epithelial cells remains ill-explored.
 The role of TH17 in tumorigenesis is extremely controversial and seemingly 
context- and tissue-dependent102-106. TH17 cells were found to play a role in developing 
colonic tumors, and blockade of  IL-17A with a neutralizing antibody inhibited the 
progression of  tumors105.  Additional models have shown that IL-17A knockout impairs 
melanoma and bladder carcinoma growth107, and skin tumor formation108, while 
overexpression of IL-17A in cervical tumors promote tumorigenicity104. Whether IL-17A 
contributes directly or via stimulation of  IL-6 and IL-8 remains unclear. At minimum, it 
appears to be a member of another feedforward loop between TH17 cells and fibroblasts 
that lead to the expression of  IL-17A and IL-6, respectively32. This may directly fuel the 
NFkB, Lin28B, Let7 feedforward loop described in the previous section. Conversely, 
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similar approaches have also shown that IL-17A can slow  growth and progression by 
inducing reactivity to CD8+ cytotoxic T lymphocytes102,103. While TH1 and TH2 responses 
are very dichotomous, suppressing each other’s development and activation, TH17 cells 
are less inhibited by TH1 and TH2 cytokines, and indeed, can frequently be found 
admixed with TH1 responses87,91. This has made it difficult to pinpoint the mediators that 
are pro- and anti-tumorigenic. Therefore, it will be imperative to delineate whether 
IL-17A promotes carcinogenesis directly, or via additional cytokines, and under what 
circumstances/in the setting of what cellular company is anti-tumor immunity avoided.
VII. Myeloid lineages
 The classic model of  myeloid differentiation, whereby a common myeloid 
progenitor give rise to monocytes, which terminally differentiated into macrophages upon 
arrival at the site of residence, have recently been challenged/further defined by 
identification of  intermediates that co-express discrete markers (Figure 3)109. More 
specifically, in a variety of  tumor models, including H. felis infection, CD11b+Gr-1+ 
“immature myeloid cells” (IMCs) are mobilized from the bone marrow  and found at 
elevated levels in the blood110,111. Upon encountering ill-defined factors (frequently 
tumor-derived, candidates that include IFNγ, CSF-1, IL-6, IL-10, VEGF, and GM-CSF), 
they acquire a phenotype characterized by suppression of anti-tumor immunity (primarily 
affecting CD8+, but to a lesser extent, CD4+ T cells) and direct promotion of 
carcinogenesis and metastasis, and are commonly termed “myeloid derived suppressor 
cells” (MDSCs)112-114. MDSCs achieve this suppression in a variety of ways, in both 
antigen-specific and non-specific manners, including, but not limited to, the production of 
reactive oxygen species (ROS), nitric oxide (NO), TGF-β, nitration of  TCR and CD8, and 
deprivation of arginine and cysteine from the local environment (which are both required 
in T cell activation and effector function)47,115. They can directly promote carcinogenesis 
and metastasis through the production of  cytokines and MMPs, and promote tumor 
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angiogenesis116,117. Both IMCs and MDSCs use the surface markers CD11b+Gr1+ and 
could simply represent different phenotypic states of  the same heterogenous myeloid 
population, the latter immunosuppressive while the former not; from this point on, the 
term IMC will generally be used as we have not investigated the suppressive potential of 
observed CD11b+Gr1+ cells in our studies.  
 Gr-1 is an antibody that recognizes two cell surface receptors, Ly6C and Ly6G, 
and IMCs/MDSCs were subsequently divided into monocytic-like Ly6C+ (Ly6G-) cells 
and neutrophil-like Ly6G+ (Ly6Clow) subsets114,118. Although their suppressive activity on 
a per cell basis is generally reported as comparable, in vitro differentiation of the subsets 
revealed that Ly6C+ MDSCs preferentially lose GR-1 expression and upregulate F4/80 
and CD11c, surface receptors associated with mature monocyte, dendritic cell, and 
macrophage lineages118. Ly6C has also been used to categorize two subsets of 
monocytes in mice: “inflammatory” monocytes are Ly6C+ while “patrolling” monocytes 
are CX3CR1+; this corresponds to human CD14+ and CD16+ monocytes, respectively119. 
Ly6C+ “inflammatory” monocyte concentration elevates rapidly during infection and are 
recruited to inflamed tissues where they may upregulate CD11c and F4/80120. The 
concentration of CX3CR1+ “patrolling” monocytes are more constant and thought to 
replenish resident macrophages in a wide variety of tissues119. Additional cell surface 
receptors used to characterize the various myeloid populations include CD31, CD115, 
Ly6B, making it sometimes difficult to directly compare subsets defined across multiple 
reports119,121.
 Chemokines are a large family of molecules involved in the recruitment 
(chemotaxis) of a wide variety of immune cells. They were recently renamed and 
categorized based on their structure; the CCL (ligand) family (including 28 members) 
binds to one or more of  the CCR (receptor) family (including 10 members), while one of 
the 16 CXCL members bind to one or more of the 6 CXCR members122. Although murine 
myeloid lineages have not been fully screened for chemokine receptor expression, 
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human monocytes express a number of  receptors at low  levels; two receptors with 
highest expression include CCR2 and CXCR2, binding primarily (but not exclusively) to 
CCL2, CCL7, CCL8, and CXCL1, CXCL5, CXCL8 respectively120. 
 Movement of  myeloid cells to tissues requires multiple steps, including 
mobilization from the bone marrow  into the peripheral blood, then recruitment from the 
blood to the tissue. Data regarding the role of  chemokine-receptor interactions during 
these two steps are complex and sometimes conflicting. Although, due to their high 
expression, most studies have focused on the role of  CCR2 and CXCR2. Human CD14+ 
monocytes (correlating to murine Ly6C+ monocytes) express CCR2 and CXCR2120, and 
murine Ly6C+ monocytes and MDSCs express CCR2123,124. However, expression of 
CXCR2 on these two murine myeloid subsets have not been determined directly124. 
Serbina and Pamer reported that CD11b+Ly6C+ monocytes accumulate in the bone 
marrow  of CCR2-/-mice, while adoptive transfer of CCR2-/- bone marrow  did not alter the 
ability of Ly6C+ monocytes to be recruited to spleens of  L. monocytogenes-infected 
mice125. Conversely, a role for CCR2 has been implicated in the rolling and diapadesis of 
monocytes across endothelial layers126,127, and adoptive transfer of  CCR2-/- bone 
marrow  almost completely abolished the ability of  Ly6C+ monocytes to be recruited to 
atherosclerotic lesions128. Finally, utilizing CCR2, CCL2, CCL7, CCL8, and CCL12 
knockout mice, it was shown that CCL7, and to a slightly lesser extent, CCL2 (both 
ligands for CCR2), were critical for both high-fat diet induced monocyte mobilization and 
thioglycollate-induced peritoneal recruitment129. Collectively, these data suggest that 
CCR2 and its ligands may be involved in both mobilization and local recruitment, in a 
context dependent manner. Furthermore, markers used to identify monocyte populations 
may help explain discrepancies.
 In a similar fashion, CXCR2 and its ligands (such as CXCL1 and CXCL5) have 
been implicated in both the mobilization and local recruitment of  myeloid cells. Early 
reports suggested that the CXCL1/CXCR2 axis mediates the recruitment of  monocytes 
20
to atherosclerotic lesions130. More recently, MDSCs were shown to be mobilized from 
bone marrow by CXCL1, and recruited to tumors by CXCL5131,132.
 One of  the primary terms used to describe the myeloid family of cells, and even 
many subsets, remains “heterogeneous.” While numerous studies have investigated the 
behavior of IMCs/MDSCs in tumor models at the tumor site, very few  reports have 
enumerated on their behavior and roles at non-tumor sites. Furthermore, myeloid 
lineage definition and development remains incompletely described, and inter-
relationships of monocyte subsets and IMCs/MDSCs remains unexplored; advancement 
in these areas will be a critical step in our understanding of myeloid behavior and 
differentiation potential.
VIII. Adipose inflammation and insulin resistance
 Type II diabetes is characterized by an excessive amount of  glucose in the 
bloodstream, which mediates the pathologies associated with this disease. Under 
normal homeostasis, insulin helps keep blood glucose concentration at moderate levels. 
More specifically, insulin primarily targets muscle (promoting glucose uptake), liver 
(suppressing glucose output), and adipose tissue (promoting fatty acid uptake and 
inhibiting lypolysis); however, desensitization and reduced responses to insulin, known 
as insulin resistance (IR), is frequently seen in obesity133. Fat tissue primarily consists of 
adipocytes, a cellular storage site for lipids. During excessive positive energy balance, 
they undergo hyperplasia and hypertrophy to accommodate excess lipids; although, as 
the adipose tissue grows, it becomes increasingly inflammatory134. While a variety of 
leukocytes normally reside in the stromal vascular fraction (SVF) of adipose tissue, the 
number of  bone marrow-derived myeloid cells in adipose tissue dramatically increases in 
obesity, and is generally correlated with adipocyte size and body mass in both humans 
and mice135,136. Crosstalk between the adipocytes and mature adipose tissue 
macrophages (ATMs) induces production of inflammatory cytokines (generally termed 
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“adipokines”) in both populations, leading to elevated serum levels137. Of the wide panel 
of adipokines (elaborated below), ATMs were reported to be the primary source of TNFα, 
and significant amounts of iNOS and IL-6, and have been shown to mediate the 
development of IR in multiple models135,138. It is interesting to note that not all adipose 
tissue depots are equal; subcutaneous and visceral depots differ in cell size, metabolic 
activity, and ATM concentration, and are thought to contribute to insulin resistance 
differentially, whereby visceral is more lipolytic and pathogenic136,139.
 Adipocytes release free fatty acids (FFAs) which can bind to TLR2 and 4, and 
cause the activation of JNK and IKKβ (and therefore NFκB) in infiltrating myeloid cells, 
leading to the development of  IR within adipose tissue140,141. Furthermore, adipose 
tissue produces a wide variety of  adipokines that positively (such as leptin, adiponectin, 
omentin and vaspin) and negatively (such as resistin, retinol binding protein 4, IL-6, 
TNFα, IL-1β) affect insulin sensitivity in other peripheral tissues133,142. The secreted 
adipokines can activate JNK and IKKβ in these distal tissues to interfere and counteract 
insulin signaling and its pathways133,139. Knockout of  IKKβ in hepatocytes retained liver 
insulin sensitivity while IR developed in muscle and fat when challenged with dietary or 
genetic obesity143. Furthermore, expression of  constitutively active IKKβ in hepatocytes 
leads to spontaneous development of hepatic IR and production of pro-inflammatory 
cytokines which induced moderate IR in other tissues, such as muscle144. When placed 
on a HFD, Lys M-mediated “myeloid-specific” IKKβ or JNK1 knockout animals gain 
weight comparable to WT animals, but are relatively protected from glucose intolerance 
and hyperinsulinemia143,145. Interestingly, these mice displayed a similar extent of hepatic 
steatosis and increased intramuscular triglyceride content, indicating that tissue lipid 
overload can be dissociated from IR when there is an absence of inflammation. 
 While inflammatory mediators likely play a major role in insulin resistance, 
supportive roles are also played by accumulation of fatty acid intermediates and 
activation of  ER stress pathways146. Furthermore, interference of insulin signaling and its 
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pathways is not the only means by which inflammatory mediators can affect IR. It has 
been suggested by multiple models that IR develops when depots are unable to 
appropriately expand to accommodate excess lipids, and therefore disruption of 
adipogenesis and lipid uptake promotes IR development147. Indeed, TNFα and IL-6 are 
just two mediators that have been shown to inhibit adipocyte differentiation148,149, while 
expansion of  adipose tissue actually improves insulin sensitivity, as seen in transgenic 
mice that overexpress adiponectin150. Additionally, TNFα and IL-6 have been shown to 
inhibit lipoprotein lipase activity, which is required for hydrolysis of circulating 
triglycerides and deposition of fatty acids into adipocytes148,151,152.
 It has been recently noted that not all myeloid populations in the adipose tissue 
are similarly pathogenic. Calorie restriction leads to the breakdown and release of  FFA 
and transiently recruits F4/80+CD11c- macrophages to adipose tissue, which did not 
secrete pro-inflammatory cytokines153. Additionally, it was reported that 
CD11b+F4/80+CD11c+ dendritic cell-like myeloid cells in adipose tissue isolated from 
high-fat fed or ob/ob (leptin deficient obese) mice were the primary source of TNFα, IL-6, 
and IL-1β, when compared to CD11b+F4/80+CD11c- monocyte-like myeloid cells140. 
Furthermore, ablation of CD11c+ cells lead to a rapid normalization of insulin sensitivity 
in mice fed a high fat diet154. CD11b+F4/80+CD11c+ myeloid cells are also found in 
skeletal muscle, primarily localized to intermuscular adipose depots, and may also 
mediate the development of IR in this tissue133.  
 As noted in the previous section, myeloid cells express the chemokine receptors 
CCR2 and CXCR2 at a much higher level than others, and consequently, studies 
investigating the recruitment of  myeloid cells have focused on these receptors and their 
ligands. While CCR2 knockout mice display reduced ATM content and insulin resistance 
when placed on a HFD138, knockout of CCL2 has generated conflicting reports, with data 
suggesting that it can produce effects similar to CCR2 knockout mice155, or have little to 
no effect156. Furthermore, overexpression of  CCL2 from adipose tissue leads to ATM 
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accumulation and insulin resistance155, collectively suggesting that the CCL2/CCR2 axis 
probably plays a major, but not exclusive role in the recruitment of myeloid cells. Another 
receptor highly expressed on myeloid lineages is CXCR2, and similar to data from the 
CCR2, knockout of CXCR2 leads to a decrease of ATM content and improved insulin 
sensitivity157. To date, there are no reports on the effect of  knocking out, or 




I. The K19kras model and phenotype
 Helicobacter-related gastric cancer arises through a multistage progression that 
involves the conversion of normal gastric epithelium to regions of  hyperplasia, dysplasia 
and finally, invasive adenocarcinoma. This multistep process is associated with the 
accumulation of  genetic and/or epigenetic alterations in the target cell population that 
leads to their malignant transformation. Helicobacter infection contributes to the 
pathogenesis of gastric cancer in a large part through the induction of  chronic 
inflammation159, which can induce proliferation and thus opportunity for mitotic error.  In 
addition, Helicobacter infection can promote the development of  cancer through 
mobilization and recruitment of  BMDCs that contribute to cancer development in diverse 
ways111,160,161.
 However, while chronic inflammation can likely initiate and promote oncogenic 
mutation and transformation, accumulating data suggests that in many cases the 
converse is also true, and that oncogenic mutations can also lead to the development of 
chronic inflammation162. Cytokines and soluble mediators produced by oncogene 
mutations in cancer cells recruit and activate inflammatory cells to develop a tumor 
microenvironment, which further stimulate tumor progression162,163.
 One oncogene that has been strongly linked to the development of chronic 
inflammation has been the Ras oncogene164. Expression of a mutant K-ras oncogene 
induces strong immune responses through activation of cytokines and T cells165,166.  In a 
previous report, K-ras-V12 was expressed in the gastric epithelium using the K19 
promoter, and resulted in mucus metaplasia and parietal cell loss167. However, a detailed 
investigation the inflammatory responses and development of  dysplasia in this model 
has not yet been examined. K19 is a member of the family of intermediate filaments that 
is highly expressed in and above the proliferative zone of the gastrointestinal tract167,168. 
In the stomach, K19 is expressed in the neck/isthmus region of  the glandular unit, in the 
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same area where stem/progenitor cells reside167,168.
 To assess the effects that the 2.1kb K19 promoter-driven mutant K-ras-V12 
oncogene has on the induction of chronic inflammation, we first investigated the gross 
appearance, gastric histopathology, and inflammatory responses in K19kras transgenic 
mice in comparison to H. felis-infected wild type (WT) mice over time. Wet stomach 
weight and the ratio of wet stomach weight to body weight of  K19kras mice were 
significantly higher than those of control mice, regardless of  H. felis infection (Figure  4). 
This was consistent with the gross appearance of  the stomach, where severe mucosal 
thickness and enlarged folds was consistently observed in K19kras mice (Figure 4). 
 Histopathologic scoring of  H&E-stained gastric tissue sections from mice in 
each group using previously published criteria169,170 showed that H. felis-infected WT 
mice exhibited much greater chronic active gastritis, oxyntic atrophy, intestinal 
metaplasia, hyperplasia, and dysplasia that progressed over time (Figure 5), consistent 
with the multistage model of  Helicobacter-related gastric carcinogenesis170. Inflammation 
scores in K19kras mice were similar to that of WT mice with H. felis infection. K19kras 
mice also developed oxyntic atrophy, pseudopyloric metaplasia, hyperplasia, and 
dysplasia by 3 months, and the lesions persisted until the end of  the study (Figure 5). 
Mucous metaplasia, characterized by replacement of  parietal cells with foamy Alcian 
blue-staining H/K-ATPase- cells without glandular dysplasia, was observed in the oxyntic 
mucosa of K19kras mice, but was minimal in H. felis-infected WT mice, and absent in 
uninfected WT mice (Figure 6), consistent with previous reports167,170. These results 
demonstrate that K-ras mutation in epithelial cells is sufficient to induce chronic 
inflammatory responses in the gastric epithelium.
 We followed a cohort of aged mice, combining data from mice that survived 16 
to 21 months of age, to investigate possible progression of the gastric preneoplastic 
lesions. As expected, K19kras mice and H. felis-infected WT mice continued to exhibit 
higher inflammation scores when compared to WT mice without H. felis infection, 
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Figure 4: Gastric Appearance and Weight of K19kras Mice
Gross representative pictures of mice in the three cohorts. Gastric and body weights 
were measured during sacrifice, whole stomach weights and ratio of stomach to body 
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Figure 5: Histopathological Scores of K19kras Mice 
Histopathology scores for gastric lesions of mice 3, 6, and 12 months after H. felis 



















Figure 6: Gastric Histology of Middle-Aged K19kras Mice 
H&E- and alcian blue-stained gastric tissue sections. Representative Alcian blue+ cells 
in WT, H. felis infected mice are indicated by arrows, magnified insets are of boxed 
regions (original magnification 100x and 150x, respectively; 12 month time point).
becoming progressively more severe with longer observation periods (Figure 7). 
Histology scores for dysplasia were also elevated after long-term observation, in parallel 
with the severity of inflammation (Figure 7). Among these mice, 3 of 4 (75.0%) H. felis-
infected wild type mice and 3 of 8 (37.5%) K19kras mice developed gross papillary 
tumors in the stomach (Figure 7). The lesions of three K19kras mice were histologically 
defined as high-grade dysplasia or intramucosal carcinoma, with some areas invading 
into sub-mucosal layers (Figure 7).
II. Expansion of Dcamkl1+ cells
 The progression to metaplasia and dysplasia in the stomachs of  K19kras mice 
was associated with changes in epithelial differentiation and proliferation. In the stomach 
of normal WT mice, K19 staining was observed primarily in pit cells which comprised the 
upper one sixth of  the gastric glands (Figure 8). Ki67+ proliferating cells reside in the 
isthmus and upper neck region, in close proximity to rare Dcamkl1+ cells found in this 
region (Figure 8). Throughout and below  the neck region are H/K-ATPase+ parietal cells, 
which make up the majority of glands (Figure 8). 
 The gastric epithelium of K19kras mice at 12 months of  age displayed obvious 
parietal cell loss, with only a small number of H/K-ATPase+ cells remaining at the base of 
the gastric glands (Figure 8). Excluding these rare parietal cells, a majority of  the 
remaining cells were mucus-producing K19+ pit cells (Figure 8), which had expanded to 
comprise nearly 2/3rds of the entire gland, consistent with previous reports167. Ki67+ 
proliferating cells shifted over time from the neck region to the bottom of  gastric glands, 
slightly above the remaining parietal cells. Interestingly, the number of  Dcamkl1+ cells 
increased markedly to many cells in each glandular unit, located just below  the 
proliferative zone and just above the residual parietal cells (Figure 8).  It should be 
noted again that Dcamkl1 is currently a candidate stem/progenitor marker, and purely 


















Figure 7: High-Grade Dysplasia Develops in Old K19kras Mice
Gross presentation of the stomachs with papillary tumors from a WT, H. felis infected 
mouse at 19 months (7445) and K19-kras mice at 16 to 19 months (9003 and 7456, 
respectively) (top).  Histopathology scores for inflammation and dysplasia in gastric 
lesions of mice between 16 and 19 months (middle). H&E-stained gastric tissue 
section of a K19-kras mouse at 16 months displaying submucosal penetration of 

























Figure 8: Altered Structure/Composition of Middle Aged K19kras Mice
Immunohistochemistry for K19, H/K ATPase, Ki67, and Dcamkl1 in gastric tissue 
sections of uninfected WT and K19-kras mice (arrows indicate Dcamkl1+ cells; original 
magnification 150x).
nonetheless, it is important to identify and characterize all cell types frequently found 
expanded in low and high grade dysplastic tissues.
 In older K19kras mice, immunohistochemistry on serial tissue sections revealed 
that the lower portions of glands contained a low  to very high number Dcamkl1+ cells 
(Figure 9). More apical regions of these glands typically contained strongly-staining 
K19+ cells, consistent with a surface epithelial phenotype (Figure 9). However, K19 
expression was clearly distinct from Dcamkl1, and colocalization of these markers was 
never observed in these serial sections or double immunofluorescence (arrow  heads in 
Figure 9 & 10). Similar immunohistochemical observations were made in regions of 
high-grade dysplasia, where Dcamkl1+ cells were expanded but never coexpressed K19 
(arrows in Figure 10). Proliferating Ki67+ cells typically resided between the 
aforementioned cell types, although they were rarely K19+ (Figure 10). Although we 
cannot completely exclude the possibility that the observed expansion of Dcamkl1+ cells 
is due to expression of K-ras in these cells, the lack of colocalization with K19 suggests 
that it is more likely due to alterations in paracrine signals and/or their niche. 
III. Cytokines and chemokines expressed
 The finding of  chronic inflammation in K19kras mice suggested that K-ras 
mutation in gastric epithelial cells triggered the activation of  specific immune responses 
that may be similar to H. felis-related chronic gastritis. qRT-PCR analysis of mice 6-12 
months of  age revealed increased gastric mRNA expression of  IL-6 and IL-1β in both H. 
felis infected WT and K19kras mice, compared to WT uninfected controls (Figure 11). 
Additionally, CXCL1 was upregulated in both these groups, while the expression of 
CXCL5 was up regulated only in K19kras mice (Figure 11). Interestingly, CXCL1 and 
IL-6 expression retained the highest degree of correlation with dysplasia scores in 
K19kras mice (Figure 11). Similar trends were observed for IL-1β and CXCL5, albeit 











Figure 9: K19 and Dcamkl1 are Differentially Expressed in Glands
Immunohistochemistry for Dcamkl1 and K19 in K19kras gastric tissue sections (from 
16-19 month time points). Serial sections at low magnification (top; original 
magnification 40x) and higher magnification (bottom left; arrows indicate Dcamkl1+/
K19- cells surrounded by K19+ cells, magnified in insets; original magnification 200x). 





Figure 10: K19 and Dcamkl1 Remain Differentially Expressed in Dysplasia
Immunohistochemistry for Dcamkl1 (upper left), K19 (upper right), Ki67 (bottom) in 
serial sections from gastric tissue of a K19kras mouse (dotted line circumvents mostly 
K19+ gland with low grade dysplasia, Dcamkl+K19- cell identified with arrowhead and 
magnified in insets; arrows indicate mostly Dcamkl1+/K19- gland with high grade 
dysplasia; original magnification 300x).
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Figure 11: Gastric Cytokine/Chemokine Expression of Middle-Aged K19kras Mice
 
qRT-PCR analysis of IL-6, IL-1", CXCL1, and CXCL5 from whole corpus tissue (top 
and middle). Relationship between dysplasia score and mRNA expression of CXCL1 
and IL-6 in K19kras mice (bottom; 12 month time point; n>4 per group).
*
expression of  other detected cytokines and chemokines, including IFNγ, TNFα, CCL2, 
CCL3, and CXCL2 (data not shown). In younger (3 month) mice, expansion of pit cells 
was moderate (Figure 12).  Consequently, at this point, the aforementioned 
inflammatory cytokines were minimally elevated, while the chemokine CXCL1 was 
significantly upregulated (Figure 12), supporting a role for CXCL1 in phenotype 
development.
IV. Bone marrow-derived cell contribution to the microenvironment
 To investigate the role of  mutated K-ras in the recruitment of  bone marrow  
derived cells (BMDCs) to the tumor microenvironment, we performed bone marrow 
transplantation (BMT) studies. Bone marrow  from chicken beta actin-EGFP mice (WT/
GFP) was transplanted into K19kras or uninfected WT recipients. Twelve to 18 months 
after BMT, gastric tissues from K19kras BMT recipient mice displayed all the phenotypic 
changes of non-transplanted K19kras mice, including mucosal thickness, histological 
pathologies, shift of  the Ki67+ proliferation zone, and dramatic expansion of Dcamkl1+ 
cells. In the BMT recipient mice, only rare GFP+ cells were observed in the gastric 
mucosa of uninfected WT mice, while K19kras mice had a greater than 10-fold increase 
in the number of recruited cells (Figure 13). E-cadherin, an epithelial-specific cell 
surface molecule, was detected in all epithelial cells of the gastric epithelium, including 
dysplastic glands. More detailed analysis of the glandular areas with confocal 
microscopy revealed that, although a small number of GFP+ cells were E-cadherin+ 
epithelial cells, a majority were E-cadherin- stromal cells (Figure 13). By 12 months, an 
estimated 15% of the recruited GFP+ BMDC in the gastric epithelium of WT mice with H. 
felis and K19kras mice were myofibroblasts, as characterized by their morphologic 
appearance and co-expression of αSMA (Figure 13).
      To further understand the expansion of Dcamkl1+ cells, we observed endogenous 
















































Figure 12: Gastric Histology and Cytokine/Chemokine Expression of Young 
K19kras Mice
Representative H&E-stained gastric tissue section from K19kras mouse indicating mild 
pit cell expansion (top). qRT-PCR analysis of CXCL1 and IL-1! from whole corpus 
tissue (bottom; 3 month time point; n>4 per group; original magnification 100x).
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Figure 13: Kras Expression in K19+ Cells Recruit BMDCs to the Gastric 
Epithelium
Endogenous GFP fluorescence of BMDCs in gastric tissue sections of WT (upper left) 
and K19kras (upper right) BMT recipients (original magnification 150x), were quantified 
(lower left; 4-8 fields/group). Representative E-cadherin (red) and GFP (green) in 
gastric tissue of K19kras BMT recipients (original magnification, 200x). Representative 
double positive cell (bone marrow-derived epithelial cell) and GFP single positive cells 
(bone marrow-derived stromal cells) are magnified in inset.
 p<0.01
recipient mice. A plethora of GFP+ cells were found surrounding most clusters of 
Dcamkl1+ cells. Excessive αSMA+ stromal cells, as well as inflammatory F4/80+ 
macrophages, were typically seen surrounding these clusters, indicating that K-ras 
expression in adjacent putative progenitor cells favored an altered, inflammatory 
microenvironment (Figure 14).
 In summary, K-Ras mutation in K19-expressing putative gastric epithelial 
progenitor cells activates inflammatory pathways and induces gastric atrophy, 
metaplasia, and dysplasia in a manner that largely parallels H. felis-induced 
carcinogenesis. K-ras-dependent chronic inflammation leads to recruitment of BMDCs 
that contribute primarily to the stromal microenvironment, and correlates with expansion 
of Dcamkl1+ cells and development of high-grade dysplasia and rarely intramucosal 
carcinoma. Interestingly, H. felis infection of K19Kras mice did not accelerate gastric 
cancer progression in these mice (data not shown), suggesting that the two models (K-
ras mutation and H. felis infection) may progress through overlapping and/or non-
additive pathways.
 Stromal myofibroblasts are believed to contribute to the stem cell niche in the 
gastrointestinal tract23,171, but as yet the effects of  depleting these stromal cell 
populations is unknown. Previous studies have reported that many CAFs present in 
tumors are likely to be bone marrow  derived25, and evidence for the importance of a 
bone marrow  contribution to tumor stroma has previously been recognized22. Thus, this 
is the first study to demonstrate that K-ras mutation on its own can lead to the 
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Figure 14: Dcamkl1+ Clusters are Surrounded by Inflammatory Cells and 
Myofibroblasts
Gastric tissue sections from K19-kras BMT recipients detecting endogenous GFP of 
BMDCs (upper left) or stained for F4/80 (upper right, green) or !SMA (lower left, green) 
and stained for Dcamkl1 (all red, original magnification, 400x). Gastric tissue sections 
from control uninfected and H. felis infected WT, and K19kras BMT recipients were 
stained for !SMA, and percentage of endogenous GFP+ BMDCs also expressing 








I. The H. felis/high fat diet model and dysplasia phenotype
 The growing obesity epidemic in the United States has placed a major strain on 
overall heath and well being; in addition to its well-established contribution to 
cardiovascular disease and type II diabetes, obesity has more recently been strongly 
correlated to multiples types of cancer, including stomach, esophagus, pancreas, breast, 
colon, kidney, endometrium, and many others76,77. Obese individuals not only have a 
greater incidence of these cancers, but also progress faster, as reflected by a higher 
degree of mortality from the cancer. With these statistics, it has been estimated that 
current rates of overweight and obesity in the US account for approximately 14% of 
deaths from cancer in men and 20% of  those in women76. The epidemiological 
observations in humans have been recapitulated in mice for a number of cancer 
models81, although to date, data for a gastric cancer model has not been reported.
 To determine whether diet-induced obesity can accelerate the multi-stage 
oncogenic process of chronic H. felis infection, designated mice were chronically fed a 
HFD from three weeks post-infection until euthanasia. Compared to the chow  diet, 
where on average 13% of  calories are derived from fat, the HFD consists of 45% 
calories from fat, where 87% of  fat calories are derived from lard and 13% are derived 
from soybean oil (see Materials and Methods). Mice were weighed on a weekly basis, 
and as expected, those eating the HFD became heavier than their chow-fed 
counterparts (statistically significant beginning eight weeks after the introduction of the 
diet), while H. felis infection did not alter the weights or body composition of mice on 
either diet (Figure 15). H. felis infection leads to inflammation and dysplasia that is 
apparent upon gross view  of the stomach as whitish lesions in the normally red 
epithelium of the corpus. Quantification of the gross gastric pictures from study mice 
revealed that while the HFD alone (i.e. in uninfected mice) could not induce any 









































Figure 15: Weight Gain and Percentage Body Fat in H.felis/HFD Mice
Mice were weighed on a weekly basis throughout the duration of the study (top left; 
n>20 per group). Percentage body fat as estimated by DEXA (top right; 15 month time 
point; n>5 per group), with representative DEXA scans of mice chronically fed a chow 
or high fat diet (bottom).
significantly larger lesions when compared to H. felis-infected, chow-fed (H. felis/chow) 
mice at both time points (Figure 16). H&E-stained sections (Figure 17) were reviewed 
and blindly scored by a veterinary pathologist, which confirmed that a HFD alone did not 
induce any abnormalities in the gastric epithelium. Furthermore, H. felis/HFD mice had 
significantly higher pathological scores at both 10 and 15 month time points than H. felis/
chow  mice, including inflammation, epithelial defects, metaplasia, and dysplasia (Figure 
17). This indicates that diet-induced obesity increases both the severity and area of 
H.felis-induced pathology.
II. T-cell responses
 H. pylori and H. felis have been shown previously to induce minimal TH2 
responses yet strong TH1 and TH17 responses172,173. To investigate which of  the three 
polarized T cell responses is associated with the HFD-induced acceleration in 
carcinogenesis, we performed qRT-PCR for the quintessential cytokines expressed by 
the different subtypes: IFNγ for TH1, IL-4 for TH2 and IL-17A for TH17 on whole gastric 
tissue samples from the 15 month time point (Figure 18). IL-4 expression remained low 
amongst all groups. While there was a moderate IFNγ induction in all H. felis infected 
mice, there was no difference between H. felis/chow  and H. felis/HFD mice. For IL-17A, 
there was an approximate 8-fold increase in H. felis/chow  mice; however, there was a 
30-fold increase in H. felis/HFD mice, and this was significantly higher when compared 
to all other groups, including H. felis/chow  mice. These findings were confirmed at the 
protein level where H. felis/HFD mice had significantly more IL-17A in whole gastric 
tissue when compared to H. felis/chow mice (Figure 18).
III. Leptin and IL-6 as activators of Stat3
 To investigate the source of  this excessive TH17 response, we analyzed the 











Figure 16: Gross Characteristics of H.felis/HFD Mice
Gross pictures of stomachs from mice sacrificed at the 10 month and 15 month time 
points, dotted lines indicate areas affected by inflammation/dysplasia (top).  
Representative fine quantification of percentage corpus affected, affected tissue 
outlined in red, total corpus outlined in black (bottom left).  Average percentage corpus 
affected at both time points (bottom right; n=13-16 mice per group).
% Corpus Affected
Representative Area Quantified




















































































Figure 17: Histology and Histopathology of H.felis/HFD Mice
Representative H&E-stained gastric tissue sections from all four cohorts at the 15 
month time point (top). Histopathological scores for inflammation, epithelial defects, 
intestinal metaplasia, and dysplasia at both 10 and 15 month time points (bottom; n>6 
































































Figure 18: Gastric Cytokine Expression
qRT-PCR analysis of IFN! (top left), IL-4 (top right), and IL-17A (bottom left) from 
whole corpus tissue. Protein levels for IL17A were also quantified using ELISA (bottom 
right) from whole corpus tissue (15 month time point; n>6 per group, run in triplicate).






















its development and/or activation, and in particular, the critical and essential Stat3. In the 
setting of  obesity, expanded and stressed adipose tissue secretes a variety of 
inflammatory mediators; therefore, we first analyzed adipose-derived factors. Indeed, in 
H. felis-infected mice, very high levels of serum leptin and IL-6 could be found in HFD-
fed mice when compared to chow-fed controls (Figure 19). Both Leptin and IL-6 bind to 
type 1 cytokine receptor family members (ObR, and gp130, respectively) and signal, at 
least in part, through Stat3. Therefore, we performed immunohistochemistry in gastric 
sections of  mice from the 15 month time point for phosphorylated (active) Stat3; while H. 
felis/chow  mice had notable (primarily stromal) pStat3 staining, H.felis/HFD mice had 
extensive pStat3 in both epithelial and stromal cells (Figure 19). Together, these data 
suggest that the elevated serum IL-6 (and potentially Leptin) produced by adipose tissue 
in the setting of  obesity may skew  T cell development and/or exacerbate its activation 
while responding to an infection at a distant site through by activating Stat3. This is 
consistent with recent reports, where it has been noted that obese murine models have 
an enhanced TH17 responses in acute models of colitis and encephalomyelitis174.
IV. Generation of an HK/ATPase-IL17A transgenic mouse
 As noted earlier, the role of the TH17 lineage and its prototypical cytokine IL-17A 
in developing tumors remains controversial, while some reports support its direct role in 
promoting carcinogenesis105, others cite its induction of anti-tumor immunity106. 
Nonetheless, H. felis and pylori infection is associated with IL-17A expression173, and 
attenuation of the TH17 response is associated with prevention of gastric dysplasia 
progression175.  
 Therefore, with data from the model described above, as well as supportive data 
from other models in our lab, we decided to generate a transgenic mouse that 
overexpresses IL-17A in the gastric epithelium (Figure 20). Previous members of our lab 






































Figure 19: Serum Adipokines and Gastric pStat3 Expression
Serum protein levels of Leptin and IL-6 in overnight-fasted mice (top). 
Immunohistochemistry for phosphorylated Stat3 (pStat3; activated form) in gastric 
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Figure 20: H/K-ATPase-IL17A-IRES-GFP construct
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induce widespread production in the gastric corpus, and if  secreted, increase total 
gastric concentrations111,176. The most successful of these constructs drove expression 
of the cytokine IL-1β, which led to spontaneous tumor development111, while 
interestingly, expression of another pro-inflammatory cytokine, IFNγ, actually inhibits 
gastric carcinogenesis176. H/K-ATPase is expressed specifically in parietal cells which 
are abundant and found only in the gastric corpus (see Figure 8). Although no one has 
overexpressed IL-17A in gastric tissue or studied its carcinogenic potential, it has been 
successfully overexpressed in lung tissue to examine acute immune responses177, and 
we graciously received this CC10-IL17A construct from Dr. Chen Dong. To generate the 
H/K-ATPase-IL17A transgenic mouse, we amplified a 2.0 kilobase region (including the 
IL-17A mRNA and IRES-GFP cassette) from the donated CC10-IL-17A construct and 
inserted it into a vector containing the H/K-ATPase promoter and human growth 
hormone 3’ UTR. To date, the construct was injected by the transgenic core at Columbia 
University, 5 founders were created (as confirmed by amplification of multiple regions of 
the construct, including the entire IL17A-IRES-GFP cassette, from DNA extracted from 
mouse tail tissue), and studies are ongoing to breed and phenotype these mice during 
the coming year (Figure 20).
 Characterization of  the H/K-APTase-IL17A mouse will be exciting and critical to 
understand its role in carcinogenesis, and there are many possible phenotypes. One is 
that IL-17A overexpression directly induces tumor development, which is not completely 
implausible considering overexpression of IL-1β is able to do just this111. Another 
possibility is that IL17A induces such a high level of  anti-tumor immunity that advanced 
metaplasia and dysplasia is unable to develop. This seems somewhat unlikely, as 
reports have shown that TH1 responses broadly and consistently induce anti-tumor 
immunity whereas TH17 are much more variable106. The strongest evidence for TH17 
cells in the induction of anti-tumor immunity utilized in vitro-generated TH17 cells, and a 
tumor model on the order of days102, whereas our gastric cancer model is on the order of 
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months to years, which is more reflective of the human pathogenesis. A third possibility 
is that IL-17A actually promotes both carcinogenesis and anti-tumor immunity; in this 
case, which is likely, it will be necessary to investigate the presence of which additional 
cell types are required to induce which process and outcome. For example, IMCs may 
be required in the tumor microenvironment to suppress the CD8+ cytotoxic T cell-
mediated anti-tumor immunity, thereby allowing IL-17A’s effect on epithelial cells and/or 
other stromal cell. A fourth potential outcome is that IL-17A is only able to support the 
progression of transformed cells after an initiating factor, such as H. felis infection, to 
begin the process. A detailed analysis of the phenotype time-course, and presence and 
behavior of  additional cell types will be necessary to utilize this model properly and 
expand our knowledge of the role of IL-17A in tumor development.
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Chapter 4: Myeloid Cells
I. Metabolic phenotype of the H. felis/high fat diet model
 Adipose inflammation is imperative to the induction of  insulin resistance, although 
studies investigating the role of inflammation at a distant site affecting insulin resistance 
directly or indirectly are lacking. Furthermore, reports on the association between H. 
pylori infection and type II diabetes are restricted to humans and have remained 
inconsistent178,179. Nonetheless, we sought to investigate the affect of Helicobacter 
infection on normal weight and obese mice. As enumerated in the previous chapter, mice 
were infected with H. felis around 14 weeks of age or left uninfected as controls, and 
chronically fed ad libitum a HFD or left on the standard chow  diet. As an important 
reminder, throughout the length of  the entire study, H. felis infection did not alter the 
body weights of mice on either diet (Figure 15). Additionally, H. felis-infected mice fed a 
HFD (H. felis/HFD) had similar body composition, fasting glucose, and fasting insulin to 
uninfected mice fed a HFD (uninfected/HFD) (Figures 15 & 21). However, when 
subjected to an intraperitoneal injection of glucose, H. felis/HFD mice were significantly 
more glucose intolerant than Uninfected/HFD mice (Figure 21). Notably, H. felis 
infection did not affect glucose clearance in normal weight mice, suggesting that 
infection, per se, does not directly contribute to glucose intolerance.
II. Adipose inflammation
 It has been shown previously that insulin resistance is correlated with, and is 
dependent upon, the concentration of  myeloid cells in visceral adipose tissue. As 
expected in the adipose tissue of uninfected/HFD mice, adipocytes increased in size, 
and recruited inflammatory cells were readily observed in the stroma compared to mice 
on a normal chow  diet (Figure 22). However, while H. felis/HFD mice had a similar 
increase in adipocyte size, the stroma was enriched with inflammatory cells (Figure  22). 
To estimate stromal/inflammatory cell content, total nuclei were counted in high power 
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* vs. Uninfected, HFD  p<0.05
Figure 21: Metabolic Parameters of H.felis/HFD Mice
Mice were fasted overnight and blood was taken to measure fasting glucose and 
insulin (top). Additional mice were given intraperitoneal injection with 1 gram glucose/
kg body weight and blood glucose was measured at 15, 30, 45, 60, and 90 minutes 
post-injection (bottom left). Area under the glucose curves were calculated and 































































Figure 22: Subcutaneous and Visceral Adipose Inflammation and Adipocyte Size
Representative H&E-stained adipose tissue sections from subcutaneous (top) or 
visceral (epididymal; bottom) depots (original magnification, 200x). Total nuclei were 
counted in a high power field of adipose tissue section and compared to the number of 
adipocytes in that field (subcutaneous: 3-4 fields/group, average 77-242 nuclei/field; 
visceral: 8-13 fields/group, average 113-217 nuclei/field). Average adipocyte size was 
calculated and averaged (subcutaneous: 2-3 fields/group, 58-110 total adipocytes/
group; visceral: 3-10 fields/group, 92-275 total adipocytes/group) (15 month time 
point).



























fields and normalized to the number of adipocytes in that field. Quantification estimated 
stromal cell content to be around 1.5 to 2-fold higher in H. felis/HFD compared to 
uninfected/HFD mice. This was specific to the more inflammatory visceral tissue, as the 
overall nuclei concentration was lower in subcutaneous adipose tissue, where there was 
no difference between H. felis/HFD and uninfected/HFD mice (Figure 22). While 
numerous cell types are found in the stroma, macrophages are thought to contribute the 
most to inf lammatory cytokine production.  Therefore, we performed 
immunohistochemistry for F4/80 in adipose tissue sections and observed a similar 1.5 to 
2-fold increase (Figure 23), which was further supported by a significant increase in 
F4/80 mRNA, as detected by qRT-PCR (Figure 23). 
 Not all macrophage populations in adipose tissue induce inflammatory cytokine 
production 153, so we analyzed mRNA and protein levels in adipose tissue and serum, 
respectively, of  study mice for factors described to mediate the development of insulin 
resistance and its comorbidities. IL-6 production in adipose tissue was highly 
upregulated in H. felis/HFD compared to uninfected/HFD mice, along with a significant 
upregulation of  Saa3 (Serum Amyloid A 3) (Figure 24). Serum proteins reflected this 
trend as well, as H. felis/HFD mice had significantly higher levels of IL-6, Resistin, and 
PAI-1 compared to Uninfected/HFD mice (Figure 24). Overproduction of these 
adipokines likely account for the significantly worse glucose tolerance observed in H. 
felis/HFD mice.
III. Adipose proliferation, chemokines expressed
 The increased stromal concentration could be due to proliferation of existing 
stromal cells or chemokine-based recruitment; the latter is, in turn, dependent upon 
chemokine expression and the concentration of  recruitable (bone-marrow  derived) cells 
in the blood circulation. To investigate proliferation, we performed Ki67 























































Figure 23: Macrophage Content in Visceral Adipose Tissue
Immunohistochemitry for F4/80 was performed on adipose tissue sections (left; original 
magnification, 200x). Total number of stained cells were quantified per high power field 
(upper right; 5-6 fields/group, average 74-141 nuclei/field). qRT-PCR analysis of F4/80 
from whole adipose tissue (lower right; n>5 per group; 15 month time point).
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Figure 24: Adipose Production and Serum Levels of Adipokines
qRT-PCR analysis of IL-6, and Saa3 from whole adipose tissue (top). Serum protein 
levels of IL-6, PAI-1, and Resistin in overnight-fasted mice (bottom; 15 month time 
























infection status did not significantly change the overall percentage of  proliferating cells 
(Figure 25). To confirm these findings, and investigate whether there is a shift in the 
proliferating cell populations, we injected mice with BrdU, isolated the stromal vascular 
fraction (SVF) of  adipose tissue 18 hours later, and analyzed the SVF by flow  cytometry. 
Unexpectedly, instead of a similar or increased level of proliferation, there was actually a 
significant decrease in the percentage of BrdU+ in total SVF cells in H. felis/HFD mice 
when compared to Uninfected/HFD mice (Figure 25). This was also true for the number 
of total proliferating myeloid cells (CD11b+BrdU+ of total SVF cells), while there was no 
difference in the number of proliferating immature myeloid cells (IMCs; CD11b+
Gr-1+BrdU+of total SVF cells) (Figure 25).
 Like many other tissues, chemokines are produced by adipose tissue to recruit 
monocytes and macrophages from the bloodstream. Indeed, it has been shown 
previously that knockout of CCR2 in mice reduces adipose macrophage content in 
obese mice, resulting in a dampened inflammatory profile138. Theoretically, the H.felis 
infected stomach could produce some signal that stimulates the adipocytes and stromal 
cells within the adipose tissue to produce excessive amounts of  chemokines (Figure 26, 
left). Therefore, we analyzed adipose tissue production and serum values of the major 
monocyte chemoattractant protein CCL2, as well as the supportive chemokines CCL7 
and CCL8. We did not detect any differences in CCL2 adipose expression or serum 
concentration, and while CCL7 was modestly upregulated, CCL8 was not (Figure 27). 
Although CCL7 expression requires further investigation, to date, no reports have 
indicated that its upregulation alone contributes significantly to the recruitment of cells 
into the adipose tissue. While attempts at adoptive transfer of  GFP-expressing myeloid 
cells and tracking their recruitment to the adipose tissue have not been successful thus 
far (data not shown), we are actively optimizing this experiment as it would give 
conclusive data as to whether local recruitment plays a significant role. Nonetheless, our 














Figure 25: Proliferation Index in Visceral Adipose Tissue
Immunohistochemitry for KI67 was performed on adipose tissue sections, total number 
of stained nuclei were quantified and expressed as percentage of total cells (top; 15 
month time point; 5-14 fields/group, average 108-139 nuclei/field; original 
magnification, 300x). Mice were injected with BrdU and sacrificed 12 hours later, 
adipose tissue SVF were isolated and stained with antibodies to CD11b, Gr-1, and 
BrdU; representative flow cytometric analysis plots (middle) and overall quantification 



















































































































































Figure 26: Hypothetical Myeloid Cell Recruitment Models
62






















































































Chow HFD Chow HFD
ns
Uninfected H. felis
Figure 27: Gastric and Adipose Chemokine Expression
Serum protein levels of CCL2 in overnight-fasted mice (top). qRT-PCR analysis of 
CCL2, CCL7, and CCL8 from whole adipose tissue (middle). qRT-PCR analysis of 
CXCL1 from whole adipose or gastric corpus tissue, as well as fasting serum CXCL1 
protein levels (bottom; 15 month time point; n>6 per group). 












felis/HFD mice cannot solely be explained by excessive chemokine production, and we 
therefore explored additional possibilities.
IV. Mobilization of IMCs
 One final possibility is that the concentration of  recruitable cells are increased in 
the circulation of  H. felis/HFD mice. Again, theoretically, the H. felis-infected stomach 
could produce a signal that mobilizes additional myeloid cells from the bone marrow  into 
the blood stream, and although the adipose tissue produces the same amount of 
chemokines, more myeloid cells are recruited to the adipose tissue (Figure 26, right). 
Sander et. al. recently identified CXCL1 as a mobilizer of IMCs (CD11b+Gr1+) from the 
bone marrow, increasing circulating levels in the blood132. Therefore, we performed qRT-
PCR on gastric and adipose tissue samples, and found that CXCL1 is significantly 
upregulated in the adipose tissue of  obese mice and significantly upregulated in the 
gastric tissue H. felis-infected mice (Figure 27). Serum analysis of CXCL1 confirmed 
this additive effect, with moderately elevated levels in H. felis/chow  and Uninfected/HFD 
mice, and significantly elevated levels in H. felis/HFD mice (Figure 27).
 Flow  cytometric analysis of  spleens and blood of study mice revealed that 
uninfected/HFD mice and H.felis/chow  mice have moderate increases in circulating and 
splenic IMCs; while these figures were not statistically significant, there were consistent 
trends (p values between 0.1 and 0.2, compared to uninfected/chow) (Figure 28). The 
mobilization effects of  H. felis and diet appears to be additive, and H. felis/HFD mice 
have significantly elevated IMC levels in both blood and spleen when compared to 
uninfected/HFD mice (Figure 28). These concentrations, particularly in the blood, are 
highly reflective of  serum CXCL1 levels. To check whether these cells can be recruited 
to the adipose tissue, we isolated the adipose SVF from study mice. Of note, compared 
to uninfected/HFD mice, H. felis/HFD mice had a greater number cells isolated per gram 
of adipose tissue, supporting histological estimates (Figure 29). When analyzed by flow 
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Figure 28: Blood and Splenic Concentration of IMCs
Representative flow cytometric analysis plots using isolated cells from spleen and 
blood, stained with CD11b  and Gr-1 antibodies (top). Double-positive cells were 
quantified and averaged (bottom; 15 month time point; n>4 per group). 
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Figure 29: Adipose Myeloid Populations
Representative flow cytometric analysis plots using isolated stromal vascular cells from 
adipose tissue, stained with CD11b, Gr-1, F4/80 and CD11c antibodies. Indicated 
populations were quantified and averaged and multiplied by the total amount of cells 
isolated per milligram of tissue (15 month time point; n=3 per group). 
1.7x 1.5x
1.5x
3.4 7.7 5.2 14.3
cytometry, uninfected/HFD and H. felis/HFD mice had similar relative percentages of 
CD11b+Gr1+ IMCs, although when multiplied by the number of SVF cells isolated per 
milligram of  adipose tissue, H. felis/HFD mice had a greater total number of  IMCs when 
compared to uninfected/HFD mice (Figure 29). A similar approach was used to quantify 
mature CD11b+F4/80+CD11c+ mature macrophages that are thought to be the primary 
source of insulin resistance mediators. Again, while the relative percentages of these 
cells were similar in uninfected/HFD and H. felis/HFD mice, there was a greater absolute 
number per milligram of  adipose tissue in H. felis/HFD mice, suggesting that IMCs may 
be able to differentiate into mature macrophages at constant rate and account for the 
increased adipokine production (Figure 29). 
 In summary, inflammation-based tumor models and expanding adipose tissue 
appear to utilize a common mobilizing chemokine to elevate circulating IMC levels, and 
these IMCs can be intercepted by adipose tissue where they differentiate into 
inflammatory macrophages and exacerbate insulin resistance.
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Chapter 5: Discussion 
 Collectively, these results support a model in which multiple cell types in the 
tumor microenvironment set up a cytokine network that is critical for the initiation and 
progression of gastric cancer (Figure 30). As part of the innate immune response, IMCs 
are recruited to the gastric epithelium where they are a major source of  IL-6. TH17 cells 
are recruited later as part of the adaptive immune response, where they are a major 
source of IL-17A. While IL-6 promotes TH17 differentiation and IL-17A production, 
IL-17A also stimulates IL-6 production from other stromal cell types (including 
fibroblasts), leading to a feed-forward loop107. Additionally, Il-1β, most likely both 
epithelial- and stromal- derived, synergistically cooperates with IL-6 and IL-17A to 
stimulate the other’s production100,180. All of  these cytokines are released into the 
environment and are meant to activate proximal (immune) cell types, although activation 
of unintended distal cell types, such as epithelial cells, cannot be avoided. In epithelial 
cells, NFκB and Stat3 lead to the activation of a wide variety of mechanisms known to 
stress the cell (leading to genetic mutations) and promote pro-survival and anti-apoptotic 
pathways. If epithelial cells receive these signals in a transient or undulating manner, 
they may be able to escape and successfully undergo apoptosis. However, responses 
that cause strong and unrelenting NFκB and Stat3 activation likely lead to accelerated 
transformation and expansion of gastric cancer cells. 
I. Myofibroblasts
 In addition to contributing cytokines, myofibroblasts are also likely sources of 
morphogens and growth factors that regulate stem cell homeostasis. Disruption of  this 
homeostasis can possibly lead to expansion of  stem cells/undifferentiated progenitors, 
thereby increasing the pool of  targets that are more likely to survive upon transformation. 
An additional group of morphogens that could play a role in this process includes the 
BMPs (Bone Morphogenic Proteins), as expression of  BMP2 and 4 are dysregulated in 
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Figure 30: The Gastric Tumor Microenvironment Model















H.pylori-infected stomachs181. Currently, it is unknown whether SHH and BMPs signal 
directly back to stem cells or the stem cell niche, and in general, the interaction of  these 
and other morphogens and growth factors are essentially uncharacterized in stomach 
tissue homeostasis. However, the stem cell niche cells likely play an important role, with 
the consistent characterization of desmoplasia in gastric tumor models, and frequent 
interaction of epithelial and stromal cells in the development and maintenance of  other 
tissues.  Nonetheless, our and other labs are actively developing models to characterize 
and manipulate (e.g. overexpress or knockout) the behavior of gastric stromal cells 
utilizing fluorescent labeling and Cre recombinase technologies. It will be extremely 
interesting and important to elucidate the role of  these fibroblastic populations in the 
K19kras, H. felis, and other models.
II. TH17
 While IL-17A is the quintessential cytokine for TH17 cells, numerous other cell 
types have been reported to produce it, including natural killer (NK) cells, NKT cells, 
neutrophils and some myeloid cells182. It will be important in future studies to confirm and 
characterize the source(s) of IL-17A. Furthermore, it should be noted that IL-17A is not 
synonymous with TH17, as TH17 cells can produce a wide array of additional cytokines, 
including, but not limited to, IL-17F and IL-22. Furthermore, an elevation of  both IL-6 and 
leptin are seen in H.felis/HFD mice; while IL-6 is clearly a pivotal cytokine in TH17 
development and activation, the role of leptin, which can also activate Stat3 in a variety 
of cell types, including lymphocytes183-185, should be investigated.  It should be noted 
that RNA analyses for IL-17A (via RT-PCR) have given consistently high fold changes 
while protein analyses (via ELISA) have been less dramatic; this discrepancy could be 
due to multiple reasons.  First, post-transcriptional regulation could prevent effective 
translation and release of the cytokine, although this has not been reported by other 
investigators. Secondly, it could be due to the currently very limited number of  antibodies 
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and kits available for protein analyses, and nonspecific binding of  other proteins found in 
gastric tissue extract could mask the true concentrations found in the tissues. Thirdly, the 
ELISA kit used only recognizes the IL17A/A homodimer, while a potentially significant 
portion of IL-17A may be found in the IL-17A/F heterodimer. We believe the discrepancy 
is likely explained by a combination of the latter two possibilities, but it will be necessary 
to perform western blot analyses and an IL-17A/F ELISA to appropriately analyze the 
current data. Furthermore, the H/K-ATPase-IL17A mouse will prove extremely useful in 
correlating gastric RNA expression and protein content.
III. Myeloid Cells
 The contribution of Helicobacter infection in the development of insulin resistance 
is extremely preliminary, and many questions need to be answered. First of all, H. felis 
infection appears to have little to no affect on lean mice; therefore, at what point during 
weight gain can (significant) differences be observed? We are currently undertaking 
these experiments by following a new  cohort of mice and checking glucose tolerance on 
a monthly basis and adipose inflammation at regular time points. Next, can this 
phenotype be reversed over time with the treatment of antibiotics? Helicobacter 
eradication regimens have been characterized for both mice and humans; it is expected 
that without an inflammatory stimulus, the levels of blood IMCs should fall, and 
eventually, adipose inflammation subside back to that seen in uninfected individuals. A 
time course for this kind of  subsidence is completely undescribed, although again, 
experiments are underway to address this issue. Another important next step that is 
fundamental to myeloid biology is the further characterization of mobilized and recruited 
cells. While IMCs are broadly defined by CD11b and GR-1 expression, this includes a 
very heterogeneous group of cells, and can be initially broken down by expression of 
Ly6C (more monocyte like) and Ly6G (more neutrophil like)118. Furthermore, 
characterization of  monocytes involved in other processes, such as atherosclerosis, 
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have been identified with markers such as Ly6B, CD115, and CD31. It will be important 
to characterize chemokine receptor expression in myeloid cells at all stages of 
maturation to fully understand their mobilization and recruitment. In the near future, it will 
also be important to interweave our understanding of monocytes and IMCs/MDSCs, 
which are currently essentially two separate fields. 
 Studies in both mice and humans have consistently found that myeloid cell 
concentration in adipose tissue is correlated with body weight and adipocyte size135,136. 
A recent report broke this dogma, finding that myeloid cells are transiently recruited to 
adipose tissue during fasting, a period during which adipocytes undergo excessive 
lypolysis; however, these myeloid cells did not express inflammatory cytokines or induce 
IR153. Therefore, our data are the first to find excessive IR-mediating myeloid 
concentration in adipose tissue irrespective of body weight and adipocyte size, and this 
may help explain variability in humans, where body weight and composition are not 
perfectly correlated with IR. It is also interesting that the excessive amounts of circulating 
leptin does not lead to significant changes in the body weights of  H.felis/HFD mice. 
Currently, we can only speculate that this is due to the concomitant increase of other 
pro-inflammatory cytokines, as activation of NFκB in hypothalamic circuits has been 
shown to induce leptin resistance186, although this is another highly interesting area to 
investigate.
 Clearly our ultimate goal is to treat diabetes and cancer in humans, not mice, so 
it must be asked, does this translate to humans? If  so, then at what body mass index 
(BMI) do these effects become significant? Human myeloid cells frequently do not use 
the same surface markers as murine myeloid cells, and it will be necessary to identify 
which populations are mobilized from the bone marrow  and recruited to the adipose 
tissue. Finally, does only Helicobacter infection lead to this phenotype or do additional 
secondary sources of  inflammation lead to similar observations? TPA (12-O-
tetradecanoylphorbol-13-acetate) treatment on the skin also induces the mobilization of 
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IMCs into the bloodstream110, and if our model is correct, we should be able to detect 
CXCL1 expression from treated skin, and the eventual development of IR. 
IV. Conclusion
 In summary, our data contribute significant knowledge on the behavior of  multiple 
components of the tumor microenvironment that are relevant to not only gastric 
carcinogenesis, but that of  many other tumor sites. We also describe unintended effects 
through the interaction of two sources of inflammation by skewing (TH17) and mobilizing 
(IMCs) cell types involved in these immune responses. There are likely numerous other 
avenues to discover and explore, namely in the areas of diabetes and cardiovascular 
disease. The impact of Helicobacter infection and other secondary sources of 
inflammation is expected to be much broader than the small percentage that develop 
gastric ulcers or cancer. Furthermore, current rates of obesity are high and only growing, 
and relatively little is known about how  the immune system in these individuals is 
altered.  Investigating tumor (as well as other) models will not only provide clues into 
effective treatments for this population, but will also provide insights into the 
fundamentals of other diseases and critical factors for their progression. 
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Chapter 6: Materials and Methods
Mice
  8-12 week-old male C57/BL6 mice were purchased from Jackson Laboratories 
(Bar Harbor, ME) and maintained under specific pathogen free conditions, and rules set 
forth by Columbia University’s Institutional Animal Care and Use Committee. Mice were 
fed ad libitum either a standard chow  diet (PicoLab Rodent Diet 20, 13% of  calories from 
fat) or a HFD (Research Diets, Inc. D12451; 45% of  calories from fat; 36.3% saturated, 
45.3% monounsaturated, and 18.5% polyunsaturated) and weighed on a weekly basis. 
Fasting involved overnight (12 hour) withdrawal of all food. Percentage body fat was 
measured by DEXA (Piximus) after anesthetizing with 0.2 mL of a Ketamine/Xylazine 
solution (0.2/0.1 mL with 0.7 mL PBS). The K19-K-ras-V12 (K19-kras) transgenic mice 
were generated previously167, using a 2.1-kb genomic fragment of the 5`flanking region/
promoter of the mouse K19 gene linked to the full-length mutant human K-ras (Val 12) 
gene. K19-K-ras-V12 transgenic mice were backcrossed to C57/BL6 mice for at least 3 
generations and genotyping of  offspring were performed using PCR with sense primer 
(5-GGCTGGCGTGGAAATATTCT-3’) and antisense primer 
(5-GCTGTATCGTCAAGGCACTC-3’) recognizing a sequence specific of  the transgene. 
The PCR ran at 94ºC for 2 min, then 35 cycles including 94ºC for 30 sec, 55ºC for 30 
sec, and 72ºC for 30 sec, then 72ºC for 7 min. HKATPase-IL17A-IRES-GFP mice were 
genotyped with sense primer (5’-AACGGCATCAAGGCGAACTTCA-3’) and antisense 
primer (5’-TTACTTGTACAGCTCGTCCATGCC-3’) recognizing a sequence within the 
transgene, using the protocol above and an annealing temperature of 58ºC. The 
sequence was also confirmed by amplifying the entire IL17-IRES-GFP construct (see 
below). Chicken beta-actin-EGFP and UBC-GFP transgenic mice (8-10 weeks old) were 
also purchased from Jackson Laboratories. 
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H. felis infection, histopathology, and immunohistochemistry
 H. felis infection was carried out by gavage as previously described111, mice 3 
months old received 0.5 mL inoculation of H. felis (American Type Culture Collection 
49179) by oral gavage three times at 2-day intervals using a sterile oral catheter. The 
organism was grown under microaerobic conditions on Trypticase Soy Agar (TSA II, 
Becton Dickinson, MD) supplemented with 5% sheep blood, harvested and inoculated 
(at a titer of  1010 organisms per mL) in Trypticase Soy broth (with 10% glycerol) and 
frozen at -70°C. Prior to use, aliquots were thawed, analyzed for motility, and cultured for 
evidence of aerobic or anaerobic bacterial contamination. After euthanasia, stomachs 
were photographed, tissues were fixed in 10% neutral buffered formalin, and routine 
gastric H&E sections were reviewed by board-certified veterinary pathologists and 
graded according to previously defined criteria169,170. Percentage of  corpus affected was 
estimated by circumventing the developing tumors and total corpus on digital gross 
pictures and calculating their areas in Adobe Photoshop. Adipocyte areas were 
quantified using Image Pro. Immunohistochemistry was performed on 5 µm sections with 
avidin-biotin-peroxidase complex kits (Vector Laboratories) and counterstained with 
Mayer's hematoxylin. For primary antibodies, anti-F4/80 (eBioscience), anti-Ki-67 
(abcam), anti-Stat3 (Cell Signaling Technology), anti-Hydrogen/Potassium ATPase (H/K-
ATPase) beta (1:2000; Affinity BioReagents, Golden, CO), anti-cytokeratin 19 (Abcam 
and University of  Iowa Hybridoma), and anti-Dcamkl1 (Abagent) were diluted in PBS 
with 2% FBS at a concentration of 1:100 (unless noted above), and incubated with 
sections overnight at 4ºC. 
Immunofluorescence
 Stomachs were subjected to 4-6 hours in vitro fixation with 4% 
paraformaldehyde at 4ºC, followed by equilibration in 30% sucrose overnight at 4ºC, 
embedding in OCT, frozen, prepared into 5 µm sections and used for 
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immunofluorescence. For primary antibodies, anti-E-cadherin (Zymed, South San 
Francisco, CA), anti-CD45 (eBioscience), anti-αSMA (Abcam), anti-cytokeratin 19 
(Abcam and University of Iowa Hybridoma), and anti-Dcamkl1 (Abagent) were diluted in 
PBS with 2% FBS at a concentration of  1:100 and incubated with sections overnight at 
4ºC. Following overnight incubation at 4°C, Texas Red conjugated secondary antibodies 
(Jackson ImmunoResearch) were diluted in PBS with 2% FBS at a concentration of 
1:300 and incubated with sections for 2 hours at room temperature.  Nuclei were stained 
with DAPI, and mounted using Vectashield (Vector Laboratories) for microscopy.
Protein Analyses
 Gastric samples were snap frozen, homogenized in Tris-buffered RIPA (Boston 
Bioproducts), and total protein content was quantified (BioRad). Samples were analyzed 
by an IL-17A ELISA (eBioscience), following manufacturers’ protocols. 
Serum Analyses
 Mice were fasted overnight and blood was collected by a submandibular 
puncture or by cardiac puncture (during euthanasia).  Glucose was measured by a 
OneTouch Ultra glucometer (if  samples were above the detection limit of 500 mg/dL, 
they were rounded down to 500 mg/dL), insulin was measured by ELISA (Mercodia), and 
IL-6, CXCL1, Leptin, CCL2, PAI-1, and Resistin proteins were measured by lincoplex 
(Millipore).
Real-Time PCR analysis
 RNA was extracted from tissues using Trizol (Invitrogen) and cDNA was 
synthesized using Superscript III (Invitrogen), using manufacturer’s protocols. qRT-PCR 
reactions with QuantiTect SYBR green PCR kit (QIAGEN) and primers (20µL total) were 
run on an ABI Prism 7300 (Applied Biosystems). mRNA quantities were analyzed in 
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triplicate and normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
as an internal control. The PCR ran at 95ºC for 15 min, then 40 cycles including 94ºC for 
15 sec, 55ºC for 20 sec, and 72ºC for 30 sec. Results are expressed as relative gene 











CCL7 5’-CAGCTCTCTCACTCTCTTTCTCCA -3’5’-CTGTAGCTCTTGAGATTCCTCTTGG -3’
CCL8 5’-CTGCTCATAGCTGTCCCTGTCA -3’5’-TTCCATGGGGCACTGGATATTG -3’
CXCL1 5’-GGCCCCACTGCACCCAAACC -3’5’-TGTTGTCAGAAGCCAGCGTTCACC -3’
CXCL5 5’-GCAGGTCCACAGTGCCCTAC-3’5’-TGCGAGTGCATTCCGCTTAG-3’
Genetic Engineering
 The IL17A-IRES-GFP PCR product was generated using Platinum Pfx high 
affinity DNA polymerase (Invitrogen) using sense primer 
5’-AGGAGAGGACGGATCCACAGACAGCCCAAGCTTGATATCG-3’ and antisense 
primer 5’-TTGGGCCTTGGGATCCCCCGGGCTGCAGGAATTCTTA-3’, following 
manufacturer’s protocol.  The PCR ran at 95ºC for 4 min, then 40 cycles including 94ºC 
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for 15 sec, 55ºC for 20 sec, and 72ºC for 2 min, then 68ºC for 7 min. The HKATPase-
IL1β plasmid was digested with the endonuclease BamHI (New  England Biolabs) and 
the PCR product was cloned into the vector using In-Fusion Advantage Cloning Kit 
(Clontech), following manufacturer’s protocols.
Bone marrow transplantation
 Bone marrow  transplantation was carried out as previously described160. In 
brief, 35 C57BL/6 WT females received lethal irradiation (600 cGy), twice with a 3 hour 
interval, from a Cs137 source, then received tail vein infusion of donor whole bone 
marrow  cells (5 million cells in 200 µL). Five of the recipients did not receive donor bone 
marrow  cells infusion and served as additional controls. Mice were euthanized at 3, 6, 
and 12 months post-transplantation.
BrdU Injection
 Mice were injected twice with 10 µL/gram body weight of a 5 mg/mL BrdU in 
saline, 1.5 hours apart and sacrificed 18 hours later. Adipose tissue SVF was isolated 
and stained for cell surface markers (see below), and fixed, permeabilized, treated with 
DNase, incubated with anti-BrdU-FITC antibody (BD Pharmingen) using manufacturers 
protocols and analyzed using a BD LSRII.
Adoptive Transfer
 Bone marrow  cells were isolated from UBC-GFP mice and stained for cell 
surface markers (see below), and GFP+GR-1+CD11b+ cells were sorted and isolated 
using a BD FACSAria. 5x105 or 106 cells were injected intravenously into recipient mice 
at a concentration of  2.5x106 cells/mL in PBS and sacrificed 3 days later. Adipose tissue 
was excised and prepared for histology (see above), or SVF was isolated and stained for 
cell surface markers (see below), and analyzed using a BD LSRII.
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Flow Cytometry
 Freshly isolated adipose tissue was weighed, minced with forceps and a razor 
blade into roughly 50 mg pieces in 10 mL PBS solution 1 (PBS with 0.2% BSA, 5 nM 
EDTA) and centrifuged at 200g for 5 min. Floating adipocytes were transferred to a new 
tube and digested for 45 minutes with 3 mL/gram adipose tissue of DMEM with 0.2% 
BSA, 0.14 U/mL Liberase TM (Roche), and 50 U/mL DNase I (Sigma) with vigorous 
shaking. The solution was passed through a 250µm nylon mesh, and centrifuged at 
200g for 5 min to obtain the adipose SVF.  Spleens were crushed in 10 mL of PBS 
solution 2 (PBS with 2% FBS), passed through a 40 µm cell strainer, and centrifuged at 
200g for 5 min to obtain spleenocytes. The adipose SVF, as well as spleenocytes and 
blood were incubated with 1 mL, 1 mL, and 20 mL of BD Pharm Lyse (BD Pharmingen), 
respectively, centrifuged at 200g for 5 min, washed with respective PBS solutions, 
samples were stained with Trypan Blue (Sigma) and counted with a hemocytometer, 
centrifuged again at 200g for 5 min and diluted to a concentration of  107 cells/mL. 100 
µL (106 cells) were distributed into V-bottomed welled plates (Falcon) and incubated with 
anti-Gr-1-PerCP, anti-CD11b-APC (BD Bioscience) anti-F4/80-PE, anti-CD11c-PE-Cy7 
(eBioscience) antibodies for 30 min at room temperature, washed with respective PBS 
solutions, reconstituted in PBS solution 1 with DAPI and analyzed using a BD LSRII. 
Photographic Quantification and Statistical Analysis
 For quantification of histological sections (including data in figures 13, 15, 22, 
23, and 25), unless otherwise noted, one field was taken per sample (with one sample 
per mouse). The field was the most representative area of  the sample, and the 
photographer was blinded to the group associated with each sample. Quantification 
(also including figure 16) was also performed with sample-group association blinded to 
quantifier, and if not specified, was performed manually. Statistical analyses were 
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performed using one-tailed t test and p values <0.05 were considered significant.  Data 
are expressed as mean ± standard error of the mean. Unless otherwise noted, at least 5 
mice per study group were included in analyses, and all permutations of comparisons 
between HFD-fed vs chow-fed were statistically significant.
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